Related references
Note: Only part of the references are listed.EGFR-Mutant SCLC Exhibits Heterogeneous Phenotypes and Resistance to Common Antineoplastic Drugs
Chih-An Lin et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Small cell lung cancer transformation from EGFR-mutated lung adenocarcinoma: A case report and literatures review
Yangyang Liu
CANCER BIOLOGY & THERAPY (2018)
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
Matthew D. Hellmann et al.
CANCER CELL (2018)
Validation of the 8th TNM classification for small-cell lung cancer in a retrospective material from Sweden
Salomon Tendler et al.
LUNG CANCER (2018)
Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?
Angel Qin et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
EGFR Mutations in Small Cell Lung Cancer (SCLC): Genetic Heterogeneity and Prognostic Impact
Huarong Tang et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Incidence and mortality of lung cancer: global trends and association with socioeconomic status
Martin C. S. Wong et al.
SCIENTIFIC REPORTS (2017)
Outcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: A systematic review and pooled analysis
Elisa Roca et al.
CANCER TREATMENT REVIEWS (2017)
Clinicopathological Features and Outcome of Lung Cancer Patients with Hematological Malignancy
Fumihiro Shoji et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Small cell lung cancer in never-smokers
Maria Torres-Duran et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Clinical correlation of extensive-stage small-cell lung cancer genomics
A. Dowlati et al.
ANNALS OF ONCOLOGY (2016)
Cisplatin, etoposide, and irinotecan for relapsed small-cell lung cancer
Angel Qin et al.
TRANSLATIONAL CANCER RESEARCH (2016)
Comprehensive genomic profiles of small cell lung cancer
Julie George et al.
NATURE (2015)
RB1 dual role in proliferation and apoptosis: Cell fate control and implications for cancer therapy
Paola Indovina et al.
ONCOTARGET (2015)
Small-cell lung cancer detection in never-smokers: clinical characteristics and multigene mutation profiling using targeted next-generation sequencing
J. -M. Sun et al.
ANNALS OF ONCOLOGY (2015)
Randomized Phase III Trial of Amrubicin Versus Topotecan As Second-Line Treatment for Patients With Small-Cell Lung Cancer
Joachim von Pawel et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Small-Cell Lung Cancers in Patients Who Never Smoked Cigarettes
Anna M. Varghese et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
The Association Between Smoking Quantity and Lung Cancer in Men and Women
Helen A. Powell et al.
CHEST (2013)
Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
Helena A. Yu et al.
CLINICAL CANCER RESEARCH (2013)
Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study
D. Ross Camidge et al.
LANCET ONCOLOGY (2012)
Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer
Charles M. Rudin et al.
NATURE GENETICS (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer
Martin Peifer et al.
NATURE GENETICS (2012)
Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors
Lecia V. Sequist et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
The Applicability of the Proposed IASLC Staging Revisions to Small Cell Lung Cancer (SCLC) with Comparison to the Current UICC 6th TNM Edition
Sai-Hong Ignatius Ou et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Sequential occurrence of non-small cell and small cell lung cancer with the same EGFR mutation
Ryotaro Morinaga et al.
LUNG CANCER (2007)
Treatment of non-small cell lung cancer stage I and stage II - ACCP evidence-based clinical practice guidelines (2nd edition)
Walter J. Scott et al.
CHEST (2007)
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database
Ramaswamy Govindan et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
EGFR mutation in gefitinib-responsive small-cell lung cancer
I Okamoto et al.
ANNALS OF ONCOLOGY (2006)
Efficacy of the tyrosine kinase inhibitor gefitinib in a patient with metastatic small cell lung cancer
J Araki et al.
LUNG CANCER (2005)
Share Paper
